BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37937956)

  • 1. Solitary Pulmonary Fibroleiomyomatous Hamartoma on 18 F-FDG PET/CT.
    Tao Y; Wang F; Yan J; Chen Z; He C
    Clin Nucl Med; 2024 Jan; 49(1):81-82. PubMed ID: 37937956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chondroid hamartoma presenting as solitary pulmonary nodule: results of dual time point (18)F-fluorodeoxyglucose-PET and comparison with (18)F-fluorothymidine PET and histopathology.
    Basu S; Nandy S; Rajan MG; Ramadwar M; Moghe SH
    Hell J Nucl Med; 2011; 14(2):173-4. PubMed ID: 21761023
    [No Abstract]   [Full Text] [Related]  

  • 3. 18 F-FDG PET/CT Imaging of Pulmonary Hamartomas : Metabolic and Functional Characterization.
    Usmani S; Jain A; Akhter SMJ; Al Riyami K; Abubakar S; Al Busaidi A
    Clin Nucl Med; 2023 Nov; 48(11):e537-e538. PubMed ID: 37703464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can dynamic imaging, using
    Marin A; Murchison JT; Skwarski KM; Tavares AAS; Fletcher A; Wallace WA; Salapura V; van Beek EJR; Mirsadraee S
    Radiol Oncol; 2021 May; 55(3):259-267. PubMed ID: 34051709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of pulmonary lesions with low F-18 FDG uptake using double phase F-18 FDG PET/CT: comparison of visual and quantitative analyses.
    Kim IJ; Kim SJ; Kim YS; Lee TH; Jeong YJ
    Neoplasma; 2009; 56(1):33-9. PubMed ID: 19152243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of lung hamartomas by multidetector computed tomography and positron emission tomography.
    De Cicco C; Bellomi M; Bartolomei M; Carbone G; Pelosi G; Veronesi G; De Pas T; Spaggiari L; Paganelli G
    Ann Thorac Surg; 2008 Dec; 86(6):1769-72. PubMed ID: 19021972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case report of primary pulmonary meningioma masquerading as lung metastasis in a patient with rectal carcinoma: role of
    Jiang M; Chen P; Huang R; Zhang J; Zheng J
    J Cardiothorac Surg; 2021 May; 16(1):153. PubMed ID: 34051819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules.
    Chen S; Harmon S; Perk T; Li X; Chen M; Li Y; Jeraj R
    Cancer Imaging; 2019 Aug; 19(1):56. PubMed ID: 31420006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pulmonary chondromatous hamartoma resembling multiple metastases in the (18)F-FDG PET/CT scan.
    Li L; Jiang C; Tian R
    Hell J Nucl Med; 2016; 19(2):176-8. PubMed ID: 27331216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
    Bryant AS; Cerfolio RJ
    Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of PET/CT in differentiation of malignant and benign non-solid solitary pulmonary nodules.
    Tsushima Y; Tateishi U; Uno H; Takeuchi M; Terauchi T; Goya T; Kim EE
    Ann Nucl Med; 2008 Aug; 22(7):571-7. PubMed ID: 18756359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
    Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ
    AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Taralli S; Scolozzi V; Foti M; Ricciardi S; Forcione AR; Cardillo G; Calcagni ML
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):429-436. PubMed ID: 30535767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All that glitters is not gold.
    Ahad Aziz Qureshi PA; Hassan A; Niazi IK
    J Pak Med Assoc; 2019 Aug; 69(8):1226. PubMed ID: 31431788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ¹⁸F-fluoro-deoxy-glucose focal uptake in very small pulmonary nodules: fact or artifact? Case reports.
    Calcagni ML; Taralli S; Maggi F; Rufini V; Treglia G; Leccisotti L; Bonomo L; Giordano A
    World J Surg Oncol; 2012 Apr; 10():71. PubMed ID: 22540935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of dynamic fluorodeoxyglucose positron emission tomography/computed tomography in diagnosing pulmonary arteriovenous malformation mimicking a lung tumour.
    Gungor S; Yakar Hİ
    Interact Cardiovasc Thorac Surg; 2021 Oct; 33(4):665-667. PubMed ID: 33954790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
    Maiga AW; Deppen SA; Mercaldo SF; Blume JD; Montgomery C; Vaszar LT; Williamson C; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Grogan EL
    JAMA Surg; 2018 Apr; 153(4):329-334. PubMed ID: 29117314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG PET-CT for solitary pulmonary nodule and lung cancer: Literature review.
    Groheux D; Quere G; Blanc E; Lemarignier C; Vercellino L; de Margerie-Mellon C; Merlet P; Querellou S
    Diagn Interv Imaging; 2016 Oct; 97(10):1003-1017. PubMed ID: 27567555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.
    Dewan NA; Gupta NC; Redepenning LS; Phalen JJ; Frick MP
    Chest; 1993 Oct; 104(4):997-1002. PubMed ID: 8404239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology.
    Hou S; Lin X; Wang S; Shen Y; Meng Z; Jia Q; Tan J
    Medicine (Baltimore); 2018 Aug; 97(31):e11640. PubMed ID: 30075545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.